Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Auburn National Bancorporation, Inc. reported strong second quarter 2026 financial results, with net earnings increasing to $2.3 million and earnings per share rising 27% year-over-year. The bank improved its net interest margin and asset quality, reporting minimal nonperforming assets and a negative provision for credit losses. Total assets and de…
authID announced an expanded OEM agreement with MajorKey Technologies to embed its Verified™, PrivacyKey™, and Proof™ biometric identity verification technologies directly into MajorKey’s identity security offerings. This allows MajorKey to deliver advanced privacy-preserving biometric verification across various high-risk identity workflows beyond…
Nuwellis, Inc. announced the installation of its Aquadex SmartFlow systems at a leading pediatric hospital in Wisconsin, marking its entry into a new pediatric market and expanding its footprint in critical care. The company targets growth by developing clinical protocols for Aquadex therapy, which aids precise fluid removal in critically ill child…
Firefly Neuroscience (NASDAQ: AIFF) and Next Health announced a strategic collaboration to develop a precision cognitive health platform combining Firefly's AI-powered FDA-cleared EEG/ERP brain biomarker system with personalized peptide protocols, such as Epitalon and Semax. This initiative aims to provide objective clinical measures to personalize…
Tesla has entered a long-term power purchase agreement to acquire 90% of the electricity output from Project Sterling, a large solar-plus-storage project in Arizona developed by ContourGlobal and backed by KKR & Co. The facility, scheduled to start operations in 2028, will feature 509 megawatts of peak solar capacity and 360 megawatts of four-hour …
A magnitude 7.1 earthquake with maximum intensity of 7 on Japan's scale struck Kumamoto Prefecture on Tuesday. By 6:00 p.m. local time authorities reported highway damage and closures. Analysts and past company disclosures from a similar 2016 event provide context on potential production interruptions and recovery timelines.
Clearmind Medicine Inc. announced the successful completion of treatment for all participants in Part A of its FDA-regulated Phase I/II trial evaluating CMND-100 for Alcohol Use Disorder (AUD). The company is currently analyzing the data and plans to proceed to the next trial phase, advancing its non-hallucinogenic neuroplastogen-based therapeutic …
American Eagle Outfitters is trading at bargain multiples despite Aerie and OFFLINE driving mid-20% comparable sales growth. Fundamentals - low leverage, meaningful free cash flow, and an EV/EBITDA of ~4.6 - support a long trade into the next two earnings cycles. Entry at $17.75, target $25.00, stop $14.50 for a long-term (180 trading days) swing.
Gold is trading around $4,029, down about 1.17% on the day and roughly 25.4% below six-month highs, as investors weigh a possible Fed rate move against ongoing structural demand from central banks. Technical indicators on daily and weekly charts read Strong Sell, yet heavy central bank purchases and oversold weekly momentum indicators leave scope f…
Atour is trading at a sensible earnings multiple with a $4.6B market cap, accelerating room additions and recurring dividend policy. Ahead of Q2 2026 results, the setup favors a mid-term long: buy near $34.00, target $42.00 on a successful print and guidance lift, stop at $30.50 to protect against a macro or execution shock.
India's industrial production accelerated to a 7.3% year-on-year increase in June, driven primarily by stronger manufacturing activity and higher electricity generation. The monthly figures included a methodological switch in the calculation of factory output and showed a notable acceleration in quarterly industrial growth for April-June.
Synopsys sits at the intersection of chip design software and physics-based simulation. Recent industry moves - notably NVIDIA's agent toolkits and Synopsys' broader product set following the Ansys deal - create a durable addressable market expansion. The company trades at a premium multiple today but generates strong free cash flow and has structu…
Trevi Therapeutics, a clinical-stage biopharmaceutical company developing Haduvio™ for chronic cough related to idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough, announced its management's participation in key August biotech conferences to discuss clinical progress and company strategy.
Harvard Bioscience, Inc. has scheduled the announcement of its second quarter 2026 financial results for August 11, 2026, before market opening. The company will hold a conference call at 8:00 AM ET to discuss the results, providing analysts and investors with detailed insights into its performance.
Plus Therapeutics, a clinical-stage healthcare company focused on CNS cancers, announced upcoming presentations of its ReSPECT-LM clinical program and CNSide diagnostic platform at the 2026 SNO/ASCO CNS Metastases Conference. The company will also host a sponsored symposium on leptomeningeal metastases management. Additionally, Plus Therapeutics wi…
Hubbell Incorporated (NYSE: HUBB) delivered solid Q2 2026 performance, reporting a 15% increase in net sales and a 12% rise in adjusted diluted EPS to $5.52. Organic sales growth was driven by strong demand in utility solutions and electrical solutions segments, fueled by megatrends like grid modernization and datacenter investments. Adjusted opera…
Venus Concept Inc., a leader in medical aesthetic technology, has obtained exclusive rights to distribute HIRONIC's Doublo 2.0 device in the United States and Canada. The new device, which incorporates Cold Plasma and RF microneedling technologies, has received FDA 510(k) clearance and will be launched in the US in the second half of 2026. Venus Co…
Palvella Therapeutics, a clinical-stage biopharmaceutical company focused on novel therapies for rare skin diseases and vascular malformations, will announce its Q2 2026 financial results before market open on August 4, 2026, followed by a corporate update conference call. The company is developing therapies based on its QTORIN platform, with lead …
3D Systems played a pivotal role in enabling the Defense Health Agency and Walter Reed 3D Medical Applications Center to receive FDA premarket clearance for the Titanium Cranial Plate System, the first FDA-cleared implant granted to a point-of-care institution. This milestone exemplifies the advancement of additive manufacturing in clinical environ…
Dyne Therapeutics announces FDA clearance of its Investigational New Drug application for DYNE-302, advancing its third clinical program leveraging the FORCE platform to treat facioscapulohumeral muscular dystrophy (FSHD), a rare progressive neuromuscular disorder with no approved therapies. The Phase 1 trial will assess safety, tolerability, pharm…
ZenaTech has commenced flight testing of its Interceptor P-1, a low-cost, autonomous counter-UAS drone designed to physically intercept hostile drones. This marks a significant milestone in expanding its defense portfolio with affordable counter-drone solutions integrating AI and autonomous swarm operations. The company aims to address growing glob…
Riot Platforms, Inc., a leader in large-scale data centers and bitcoin mining, announced its Q2 2026 earnings call set for August 5, 2026. The company focuses on developing digital infrastructure and mining operations across Texas and Kentucky, with engineering facilities in Denver and Houston. The press release reiterates forward-looking statement…
Nasus Pharma, a clinical-stage biopharmaceutical company developing innovative intranasal therapies, announced the appointment of pharmaceutical industry veteran Brendan P. O'Grady as CEO. O'Grady will lead the next phase of growth with an emphasis on unlocking the commercial potential of NS002, an intranasal epinephrine treatment targeting a $2 bi…
PMGC Holdings Inc., through its subsidiary A&B Aerospace, has entered a long-term manufacturing agreement with Precision Aerospace & Defense Group to supply precision-machined aerospace and defense components. Additionally, PMGC made a $500,000 strategic equity investment in PAD Group, further aligning their partnership. This collaboration position…
Kiniksa Pharmaceuticals reported robust second quarter 2026 financial results highlighted by 55% year-over-year net product revenue growth for ARCALYST®, reaching $243.6 million in Q2. The company raised its full-year 2026 ARCALYST revenue guidance to $980-$995 million. Clinical progress continues with promising Phase 2 data for KPL-387 supporting …
